Cytarabine hydrochloride CAS No.69-74-9 / Cat No.EBD17125
cytosine arabinoside hydrochloride
Cytosine beta-D-arabinofuranoside hydrochloride
1-beta-D-arabinofuranosylcytosine hydrochloride
cytarabine hydrochloride
4-amino-1-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-pyrimidin-2-one hydrochloride
IUPAC
4-amino-1-(beta-D-arabinofuranosyl)pyrimidin-2(1H)-one hydrochloride (1:1)
4-amino-1-pentofuranosylpyrimidin-2(1H)-one hydrochloride
Cytarabine HCL
1-beta-D-Arabinofuranosylcytosine hydrochloride
Cytosine arabinoside hydrochloride
Cytarabine hydrochloride
1-beta-D-arabinofuranosylcytosine hydrochloride
cytarabine hydrochloride
4-amino-1-[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-pyrimidin-2-one hydrochloride
IUPAC
4-amino-1-(beta-D-arabinofuranosyl)pyrimidin-2(1H)-one hydrochloride (1:1)
4-amino-1-pentofuranosylpyrimidin-2(1H)-one hydrochloride
Cytarabine HCL
Properties
-
Appearance:
fluffy white powder
-
Melting point:
197-198 °C(lit.)
-
Boiling point:
545.7 °C at 760 mmHg
-
Flashing point:
283.8 °C
-
Storage temperature:
2-8°C
-
Solubility:
soluble in water
Safety Information
-
Symbol:
-
Signal words:
Warning -
Hazard statements:
H317 May cause an allergic skin reaction.
H319 Causes serious eye irritation.
H341 Suspected of causing genetic defects.
H361 Suspected of damaging fertility or the unborn child.
-
Precautionary statements:
P280 Wear protective gloves/protective clothing/eye protection/face protection.
P305+P351+P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
NMR Spectrum
1H NMR
13C NMR
